New International Deal Lowers Price of Generic HIV Regimen to $75 Per Year

Drug Industry Daily
A A
A new pricing agreement will allow a leading HIV regimen to be rolled out in more than 90 low- to middle-income countries, at an average cost of $75 per patient, per year.

To View This Article:

Login

Subscribe To Drug Industry Daily